跳到主要內容區

 

  1. 首頁
  2. 系所成員
  3. 專任師資

李名鏞副教授兼系主任

李名鏞副教授
姓名： 李名鏞
職稱： 副教授兼系主任
研究室： 靜宜326
E-Mail： mylee@pu.edu.tw
分機： 15129、15050
專長： 臨床試驗、可靠度工程 、研究設計與資料分析、實驗設計

 

 

 

李名鏞　Ming-Yung Lee

最高學歷：

國立清華大學統計學博士

職　　稱：

副教授

專長學科：

[1]醫療大數據分析

[2]臨床試驗

[3]可靠度工程

[4]實驗設計

學位論文：

  1. Ming-Yung Lee (2006/8). Estimations of Lifetime Distribution and Optimal Design of Degradation EXperiments for Wiener Degradation Process. Ph.D. dissertation, 清華大學統計學研究所, 新竹.

期刊論文：

  1. Wu, Cheng-Hsun, Tsai, Tzong-Ru , Lee, Ming-Yung* (Accepted). Two-Stage Maximum Likelihood Estimation Procedure for Parallel Constant-Stress Accelerated Degradation Tests. IEEE Transactions on Reliability.[SCI]

  2. Sheng Hsu, Pei-Chun Chen, Ming-Yung Lee and Cheng-Hsun Wu (2020/4/29). Applications of an Extended Geometric Brownian Motion Degradation Model. Communications in Statistics – Theory and Methods .[SCI]

  3. 謝淑惠， 李名鏞*（出版中）。監測訪問時間的調查品質管制程序。 調查研究—方法與應用，第44期，頁7-39。[TSSCI]

  4. Hsiu-Hsiu Chiu, Wan-Ru Chao, Chi-Kuan Chen, Yi-Ju Lee, Ming-Yung Lee, Chih-Ping Han (2020/3). The Her2 gene aberrations in mucinous ovarian carcinoma: Analysis of twenty-one cases. Taiwanese Journal of Obstetrics & Gynecology, Vol. 59, No. 2, p.p.346-347.[SCI]

  5. Tsai, F.-J., Liu, H.-J., Lee, M.-Y., Lin, C.-C. (2019/3). Determination of Volatile Components from Live Water Lily Flowers by an Orthogonal-Array-Design-Assisted Trapping Cell. Applied Sciences, Vol. 9, No. 7.[SCIE]

  6. Fan, Mai-Yi, Cheng, Yu-Pin, Lee, Ming-Yung, Lin, Sung-Jan, Chiu, Hsien-Yi (2018/6/27). Efficacy and Safety of a Low-Level Light Therapy for Androgenetic Alopecia: A 24-Week, Randomized, Double-Blind, Self-comparison, Sham– device Controlled Trial. Dermatologic Surgery, Vol. 44, No. 11, p.p.1411-1420.[SCI]

  7. Cheng-Hung Hu, Ming-Yung Lee (2018/4/1). COMPARISON AMONG SEVERAL COMMONLY USED SAMPLING METHODS FOR A DEGRADATION TEST. Quality and Reliability Engineering International, Vol. 34, No. 3, p.p.436-458.[SCI]

  8. Ming-Yung Lee, Cheng-Hung Hu, and Jen Tang (2017/8/21). A Two-Stage Latent Variable Estimation Procedure for Time-Censored Accelerated Degradation Tests. IEEE Transactions on Reliability, Vol. 66 , No. 4 , p.p.1266 -1279 .[SCI]

  9. Kuang-Lee Chang, Ming-Yung Lee, Wan-Ru Chao and Chih-Ping Han* (2016/12). The status of Her2 amplification and Kras mutations in mucinous ovarian carcinoma. Human Genomics, Vol. 10 , No. 1 .[SCI]

  10. Yi-Ju Lee; Ming-Yung Lee; Alexandra Ruan; Chi-Kuan Chen; Hao-Ping Liu; Chau-Jong Wang; Wan-Ru Chao; and Chih-Ping Han (2016/11/18). Multipoint Kras oncogene mutations potentially indicate mucinous carcinoma on the entire spectrum of mucinous ovarian neoplasms. Oncotarget, Vol. 7 , No. 50 , p.p.097 -82103 .[SCI]

  11. 1. Chien-Ying Lee, Min-Chien Yu, Wu-Tsun Perng, Chun-Che Lin, Ming-Yung Lee, Ya-Lan Chang, Ya-Yun Lai, Yi-Ching Lee, Yu-Hsiang Kuan, James Cheng-Chung Wei, and Hung-Che Shih, (2016/11/12). No additional cholesterol-lowering effect observed in the combined treatment of red yeast rice and Lactobacillus Casei in hyperlipidemic patients: A double-blind randomized controlled clinical trial. Chinese Journal of Integrative Medicine, Vol. 22 , p.p.1 -8 .[SCI]

  12. Ku MC; Kok VC; Lee MY; Hsu SM; Lee PY; Chang CW; Tyan YS; Juan CW (2016/9/6). Clinical analysis of contributors to the delayed gallbladder opacification following the use of water-soluble contrast medium. Therapeutics and Clinical Risk Management, Vol. 12 , p.p.1357 -1364 .[SCI]

  13. Wan-Ru Chao; Ming-Yung Lee; Alexandra Ruan; Huang Pin Sheng; Jeng-Dong Hsu; Chih-Ping Han; Chiew-Loon Koo (2015/11). Assessment of HER2 Status Using Immunohistochemistry (IHC) and Fluorescence In Situ Hybridization (FISH) Techniques in Mucinous Epithelial Ovarian Cancer: A Comprehensive Comparison between ToGA Biopsy Method and ToGA Surgical Specimen Method. PLOS one, Vol. 10 , No. 11 .[SCI]

  14. Hui-Yu Tsai; Chun-Che Lo; Shann-Horng Yeh; Ming-Yung Lee; Tou-Rong Chene; (2015/11). Ambient and Personal Effective Dose Assessment at the International Arrival Hall of Taichung Airport in Taiwan. Archives of Environmental & Occupational Health, Vol. 70 , No. 5 , p.p.265 -271 .[SCI]

  15. Chien-Ying Lee, Min-Chien Yu, Chun-Che Lin, Ming-Yung Lee, James Cheng-Chung Wei, Hung-Che Shih (2015/8/28). Efficacy and safety of herbal medicine yun-cai tea in the treatment of hyperlipidemia: A double-blind placebo-controlled clinical trial.. Chinese Journal of Integrative Medicine, Vol. 4 , No. 21 , p.p.587 -593 .[SCI]

  16. 韓立明 ; 李名鏞 ; 蔡孟潔 ; 趙婉如 ; 韓志平 ; 王昱婷 (2015/4). Assessing the Influence of Polysomy-17 on HER2 Status in Mucinous Epithelial Ovarian Cancer: A Tissue Microarray Study Using 2010 ToGa Trial Biopsy Specimen Criteria. 婦癌醫學期刊, Vol. 4 , No. 41 , p.p.14 -23 .

  17. Cheng-Hung Hu, Ming-Yung Lee ,Jen Tang (2015/1). OPTIMUM STEP-STRESS ACCELERATED DEGRADATION TEST FOR WIENER DEGRADATION PROCESS UNDER CONSTRAINTS. European Journal of Operational Research, No. 241 , p.p.412 -421 .[SCI]

  18. Wan-Ru Chao, Ming-Yung Lee, Wea-Lung Lin, Chiew-Loon Koo, Gwo-Tarng Sheu, Chih-Ping Han (2014/9). Assessing the HER2 Status in Mucinous Epithelial Ovarian Cancer on the Basis of the 2013 ASCO/CAP Guideline Update. American Journal of Surgical Pathology, Vol. 38 , No. 9 , p.p.1227 -1234 .[SCI]

  19. Wan-Ru Chao; Ming-Yung Lee; Wea-Long Lin; Chi-Kuan Chen; Jau-Chen Lin; Chiew-Loon Koo; Gwo-Tarng Sheu; Chih-Ping Han (2014/4). HER2 amplification and overexpression are significantly correlated in mucinous epithelial ovarian cancer. Human Pathology, Vol. 45 , Col. 4 , p.p.810 -81 .[SCI]

  20. Chyong-Mei Chen; James Cheng-Chung Wei; Chao-Min Hsu; Ming-Yung Lee (2014/2/30). Regression analysis of multivariate current status data with dependent censoring: application to ankylosing spondylitis data. Statistics in Medicine, Vol. 30 , No. 5 , p.p.772 -785 .[SCI]

  21. Hui-Yu Tsai; Chun-Che Lo; Shann-Horng Yeh; Ming-Yung Lee; Tou-Rong Chen (2014/1). Ambient and Personal Effective Dose Assessment at the International Arrival Hall of Taichung Airport in Taiwan.. Archives of Environmental & Occupational Health.[SCI]

  22. Pai, Hsiang-Chu; Lee Sheuan; Yen Wen-Jiuan; Lee, Ming-Yung (Accepted). Testing of the Factor Structure of the Sexual Health Knowledge Measure With Young Adolescent Taiwanese Girls. Health Care For Women International.[SSCI]

  23. Jhi-Kai Chang; Chen-Tung Yu; Ming-Yung Lee; KJ Yeo; I-Chang Chang; Hsi-Kai Tsou; James Cheng-Chung Wei (2013/3). Tramadol/acetaminophen combination as add-on therapy in the treatment of patients with ankylosing spondylitis. Clinical Rheumatology, Vol. 3 , No. 32 , p.p.341 -347 .[SCI]

  24. Chien-Ying Lee; Min-Chien Yu; Chun-Che Lin; Ming-Yung Lee;James Cheng-Chung Wei and Hung-Che Shih (2013/2/28). Efficacy and Safety of Herbal Medicine Yun-Cai Tea in the Treatment of Hyperlipidemia: A Double-Blind Placebo-Controlled Clinical Trial. Chinese Journal of Integrative Medicine.[SCI]

  25. Ying-Hock Teng ; Jung-Jing Teng ; Ming-Yung Lee; Ming-Hong Hsieh ; Yu-Ju Chen (2013/1). Determinants of emergency medical utilization among the elderly population in Taiwan: A national longitudinal cohort study. Archives of Gerontology and Geriatrics, No. 56 , p.p.364 -369 .[SCI]

  26. Chih-Ping Han; Yu-Chen Huang; Ming-Yung Lee; En-Yu Chen; Po-Hui Wang; Shu-Ling Tzeng; Chi-Kuan Chen (2012/12). Anti-cytokeratin CAM5.2 should not be mistaken for cytokeratin 8/18 monoclonal antibody: Comment on “Spindle cell squamous cell carcinoma not expressing stratified but simple epithelial cytokeratin: Efficacy of simple epithelial cytokeratin immunoreactivity”. The Journal of Dermatology, Vol. 12 , No. 39 , p.p.72 -75 .[SCI]

  27. Shan-Ming Chena; Min-Sho Kub; Ming-Yung Lee; Jeng-Dau Tsaib; Ji-Nan Sheu (2012/8). Diagnostic performance of serum interleukin-6 and interleukin-10 levels and clinical predictors in children with rotavirus and norovirus gastroenteritis. Cytokine, Vol. 2 , No. 59 , p.p.299 -304 .[SCI]

  28. Lin SW; Wang YH; Lee MY; Ku MS; Sun HL; Lu KH; Lue KH. (2012/1). Clinical spectrum of acute rhinosinusitis among atopic and nonatopic children in Taiwan.. Int J Pediatr Otorhinolaryngol., Vol. 76 , No. 1 , p.p.70 -75 .[SCI]

  29. Yang TY, Wei JC, Lee MY, Chen CM, Ueng KC. (2011/9). A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Fufang Danshen (Salvia miltiorrhiza) as Add-on Antihypertensive Therapy in Taiwanese Patients with Uncontrolled Hypertension.. Phytother Res..[SCI]

  30. Tsai WC, Lee MY, Chen FL, Wang PH, Lin WL, Ruan A, Li YJ, Wang SC, Chiang H, Han CP. (2011/9). The HER2 gene copies per tumor cell either before or after correction for chromosome-17 correlated significantly with HER2 IHC results in epithelial ovarian cancer in a tissue microarray study. Arch Gynecol Obstet., Vol. 284 , No. 3 , p.p.721 -729 .[SCI]

  31. Lin CK, Lin WL, Chen FL, *Lee MY, Kuo JF, Ruan A, Tyan YS, Chiang H, Chou MC, *Han CP. (Accepted). Assessing the impact of polysomy-17 on HER2 status as well as the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.. International Journal of Gynecological Pathology, Vol. 3 , No. 4 , p.p.372 -379 .[SCI]

  32. Lin CK, Lin WL, Chen FL, Lee MY, Kuo JF, Ruan A, Tyan YS, Chiang H, Chou MC, Han CP. (2011/7). Assessing the impact of polysomy-17 on HER2 status and the correlations of HER2 status with prognostic variables (ER, PR, p53, Ki-67) in epithelial ovarian cancer: a tissue microarray study using immunohistochemistry and fluorescent in situ hybridization.. Int J Gynecol Pathol., Vol. 30 , No. 4 , p.p.327 -329 .[SCI]

  33. Yao CC, Lin WL, Lee MY, Han CP (2011/6). Anti-cytokeratin CAM 5.2 (B.D. Biosciences) has a primary reactivity with CK 7 and CK 8 (48 and 52 kD) rather than with the smaller molecular weight keratin breakdown fractions (50, 43, and 38 kD).. Breast Cancer Res Treat.[SCI]

  34. Lin WL, Chen FL, Lee MY, Han CP. (2011/6). Source of anti-cytokeratin CAM 5.2 reagent.. Int J Surg Pathol., No. 19 , p.p.409 -410 .[SCI]

  35. Han CP, Lin WL, Wang PH, Yang SF, Lewis JS Jr, Chen CK, Ruan A, Kuo JF, Lee MY, Chiang H. (2011/5). Overexpression of c-KIT (CD117) occurs infrequently in squamous cell carcinoma of the uterine cervix.. Histopathology, Vol. 58 , No. 6 , p.p.988 -990 .[SCI]

  36. Lin WL, Chen FL, Kuo JF, Lee MY, Han CP. (2011/4/1). Cytokeratin 8/18 monoclonal antibody was dissimilar to anti-cytokeratin CAM 5.2.--a comment on: "Discovery of two novel EWSR1/ATF1 transcripts in four chimerical transcripts-expressing clear cell sarcoma and their quantitative evaluation,. Experimental and Molecular Pathology, Vol. 90 , No. 2 , p.p.223 -224 .[SCI]

  37. Lin WL, Kuo WH, Chen FL, Lee MY, Ruan A, Tyan YS, Hsu JD, Chiang H, Han CP. (2011/2). Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancer.. Ann Surg Oncol., Vol. 18 , No. 8 , p.p.2388 -2394 .[SCI]

  38. Ming-Yung Lee (2010/12). Optimal Simple Ramp-Test Based on Wiener Degradation Processes and Inverse Gaussian Distribution. 智慧科技與應用統計學報, Vol. 8 , No. 2 , p.p.21 -34 .

  39. Han CP, Hsu JD, Yao CC, Lee MY, Ruan A, Tyan YS, Yang SF, Chiang H. (2010/11). HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.. Histopathology., Vol. 57 , No. 5 , p.p.763 -764 .[SCI]

  40. Shu-Hsin Lee, Ming-Yung Lee, Tung-Liang Chiang, Maw-Sheng Lee Meng-Chih Lee (2010/9). Child growth from birth to 18 months old born after assisted reproductive technology -results of a national birth cohort study.. International Journal of Nursing Studies., Vol. 9 , No. 47 , p.p. 1159 -1166 .[SCI, SSCI]

  41. Chen HY, Wang CY, Lee MY, Tang PF, Chu YH, Suen MW. (2010/8). A hierarchical categorisation of tasks in mobility disability.. Disabil Rehabil., Vol. 32 , No. 19 , p.p.1586 -1593 .[SSCI]

  42. Han CP, Lee MY, Kok LF, Wu TS, Cheng YW, Wang PH, Yue CH, *Tyan YS (2010/5). A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray study.. Archives of Gynecology and Obstetrics,, Vol. 5 , No. 281 , p.p.845 -850 .[SCI]

  43. Chih-Ping Han, Jeng-Dong Hsu, Ming-Yung Lee, Lai-Fong Kok, Po-Hui Wang, Yeu-Sheng Tyan, Chung-Chin Yao, (2010/5/1). True cytokeratin 8/18 immunohistochemistry is of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray study,. International Journal of Gynecological Pathology, Vol. 29 , No. 3 , p.p.282 -289 .[SCI]

  44. Chiung-Ling Liao, Jeng-Dong Hsu, Ming-Yung Lee, Lai-Fong Kok, Yi-Ju Li, Po-Hui Wang, Chung-Chin Yao and Chih-Ping Han (2010/4). Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?. Virchows Arch., Vol. 4 , No. 456 , Col. , p.p.377 -386 .[SCI]

  45. Kok LF, Lee MY, Tyan YS, Wu TS, Cheng YW, Kung MF, Wang PW, *Han CP. (2010/2). Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stain and cytoplasmic stain in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray study.. Archives of Gynecology and Obstetrics, Vol. 2 , No. 281 , p.p.293 -300 .[SCI]

  46. Han CP, Kok LF, Lee MY, Wu TS, Ruan A, Cheng YW, Wang PW, Koo CL, *Tyan YS (2010/2). Five commonly used markers (p53, TTF1, CK7, CK20, and CK34βE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension study.. Archives of Gynecology and Obstetrics,, Vol. 2 , No. 281 , p.p.317 -323 .[SCI]

  47. Hsiang-Chu Pai, Ming-Yung Lee, Sheuan Lee (2009/9). Obesity and Perimenopausal Symptoms in Mid-Life Women in Southern Taiwan.. TZU CHI Medical Journal, Vol. 22 , No. 1 , Col. , p.p.289 -296 .

  48. Han, Chih-Ping M.D., Ph.D.; Lee, Ming-Yung Ph.D.; Kok, Lai-Fong M.D.; Ruan, Alexandra; Wu, Tina S. MBA; Cheng, Ya-Wen Ph.D.; Tyan, Yeu-Sheng M.D., Ph.D.; Lin, Ching-Yi M.S., M.D. (2009/9). Adding the p16INK4a Marker to the Traditional 3-marker (ER/Vim/CEA) Panel Engenders No Supplemental Benefit in Distinguishing Between Primary Endocervical and Endometrial Adenocarcinomas in a Tissue Microarray Study.. International Journal of Gynecological Pathology:, Vol. 28 , No. 5 , Col. , p.p.489 -496 .[SCI]

  49. 3. Chih-Ping Han, Lai-Fong Kok, Ming-Yung Lee, Chung-Chin Yao, Po-Hui Wang, Yeu-Sheng Tyan, Jeng-Dong Hsu, Szu-Wen Tseng. (2009/9/18). p16INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray study. Virchows Archiv, Vol. 455 , No. 4 , Col. , p.p.353 -361 .[SCI]

  50. Han CP, Lee MY, Tzeng SL, Yao CC, Wang PH, Cheng YW, Chen SL, Wu TS, Tyan YS, * Kok LF (2008/8/2). Title: Nuclear Receptor Interaction Protein (NRIP) expression assay using human tissue microarray and immunohistochemistry technology confirming nuclear localization.. Journal of Experimental & Clinical Cancer Research,, No. 27 .[SCI]

會議論文：

  1. 李名鏞，謝淑惠 (2016/5/25)。個人資料隱私權益宣告於電話訪問調查中執行的影響。 智慧科技學會主辦，智慧科技與應用統計學術研討會。

  2. 李名鏞 (2014/6/27-2014/7/1)。The Estimation of Lifetime Distribution and Model Parameters under Two-Phase Wiener Degradation Pr。 武漢大學主辦，2014年海峽兩岸應用統計學術研討會。

  3. 李名鏞 (2014/5/16-2014/5/18)。Estimation Precision Using Two Different Data Collecting Methods for a Non-Accelerated Degradation Test。 逢甲大學, 國立中興大學主辦，2014第九屆海峽兩岸機率與統計學術研討會。

  4. Ming-Yung Lee ; Cheng-Hung Hu (2013/7). Using Latent Variable to Estimate Parameters of Inverse Gaussian Distribution Based on Time-Censored Wiener Degradation Data. Proceedings of the Institute of Industrial Engineers Asian Conference 2013 (p.p.29-35).Springer Singapore.

  5. Hu, Cheng-Hung ; Lee, Ming-Yung (2012/12). Optimum step-stress accelerated degradation testing plan based on D-optimality. 大葉大學,工業工程學會年會暨學術研討會.



研究報告（研究計畫）：

  1. 李名鏞(20190801~20200731)。在一般加速應力路徑考量下之具時間設限的最佳加速衰變實驗設計 (科技部，MOST 108-2118-M-126-001)。

  2. 李名鏞(20180801~20190731)。最佳統計漸進應力加速衰變實驗設計 (科技部，MOST 107-2118-M-126-001-)。

  3. 李名鏞(20160801~20170731)。固定應力加速衰變模型之兩階段最大概似估計及最佳加速衰變試驗設計 (科技部，105-2118-M-126-002-)。

  4. 李名鏞(20150801~20160731)。畢業生流向調查追蹤計畫：校友就業表現與在校生職能測驗關聯性分析 (校內計畫-教學研究能量精進計畫，PU104-SPR1-003)。

  5. 李名鏞(20140801~20150731)。具隨機改變點之兩相Wiener衰變模式下，產品壽命分配與參數之估計及 (科技部，MOST 103-2221-E-126 -016 -)。

  6. 李名鏞(20100801~20110731)。以Wiener加速衰變模式為基礎，在時間設限下的最佳加速衰變實驗計畫 (科技部，NSC 99-2118-M-126 -002)。

  7. 李名鏞(20091101~20100731)。加速衰變實驗之壽命分配估計與最佳實驗配置 (科技部，NSC98-2118-M-126-002)。

 

瀏覽數:
友善列印